# EDGAR Filing Document

**Accession Number:** 0001580705
**File Stem:** 0001193805-23-000181
**Filing Date:** 2023-2
**Character Count:** 9426
**Document Hash:** cda68ebff06b2140cb8b6b0258e44061
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193805-23-000181.hdr.sgml**: 20230210

**ACCESSION NUMBER**: 0001193805-23-000181

**CONFORMED SUBMISSION TYPE**: SC 13G/A

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230210

**DATE AS OF CHANGE**: 20230210

**GROUP MEMBERS**: CFRS INVESTMENTS, LLC

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** H-CYTE, INC.
- **CENTRAL INDEX KEY:** 0001591165
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **IRS NUMBER:** 463312262
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC 13G/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-88823
- **FILM NUMBER:** 23613265

**BUSINESS ADDRESS:**
- **STREET 1:** 2202 N. WEST SHORE BLVD
- **STREET 2:** STE 200
- **CITY:** TAMPA
- **STATE:** FL
- **ZIP:** 33607
- **BUSINESS PHONE:** 844-633-6839

**MAIL ADDRESS:**
- **STREET 1:** 2202 N. WEST SHORE BLVD
- **STREET 2:** STE 200
- **CITY:** TAMPA
- **STATE:** FL
- **ZIP:** 33607

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Medovex Corp.
- **DATE OF NAME CHANGE:** 20140501

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SpineZ
- **DATE OF NAME CHANGE:** 20131105
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Lynch Frederick J
- **CENTRAL INDEX KEY:** 0001580705

**FILING VALUES:**
- **FORM TYPE:** SC 13G/A

**MAIL ADDRESS:**
- **STREET 1:** C/O MASONITE INTERNATIONAL CORPORATION
- **STREET 2:** 201 NORTH FRANKLIN ST., SUITE 300
- **CITY:** TAMPA
- **STATE:** FL
- **ZIP:** 33602

**UNITED STATES<br> SECURITIES AND EXCHANGE COMMISSION<br> Washington, DC 20549**

**Amendment No. 1 to**

**SCHEDULE 13G**

**[Rule 13d-102]**

Under the Securities Exchange Act of 1934<br>

**INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO SECTION 240.13d-1(b), (c), and (d) AND AMENDMENTS THERETO FILED PURSUANT TO SECTION 240.13d-2** 

**H-Cyte, Inc.**

(Name of Issuer)

**Common Stock, $0.001 par value per share**

(Title of Class of Securities)

**404124307**

(CUSIP Number)

**CFRS Investments, LLC**

**Frederick J. Lynch**

**2903 W. Villa Rosa Park**

**Tampa, Florida 33611**

**(813) 394-2264**

(Name, Address and Telephone Number of Person<br> Authorized to Receive Notices and Communications)

**December 31, 2022**

(Date of Event Which Requires Filing of This Statement)

☐ Rule 13d-1(b)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;☒ Rule 13d-1(c)

☐ Rule 13d-1(d)

CUSIP No. 404124307

---

| | | | |
|:---|:---|:---|:---|
| 1. | &nbsp;&nbsp; <br> Names of Reporting Persons.<br>CFRS Investments, LLC | &nbsp;&nbsp; <br> Names of Reporting Persons.<br>CFRS Investments, LLC |  |
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions) | Check the Appropriate Box if a Member of a Group (See Instructions) | (a) ☐<br> (b) ☒<br>|
| 3. | SEC Use Only | SEC Use Only |  |
| 4. | Citizenship or Place of Organization<br>Florida | Citizenship or Place of Organization<br>Florida |  |
| NUMBER OF<br> SHARES<br> BENEFICIALLY<br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH | 5. | Sole Voting Power<br>0 |  |
| NUMBER OF<br> SHARES<br> BENEFICIALLY<br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH | 6. | Shared Voting Power<br>85,740 |  |
| NUMBER OF<br> SHARES<br> BENEFICIALLY<br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH | 7.<br>| Sole Dispositive Power<br>0 |  |
| NUMBER OF<br> SHARES<br> BENEFICIALLY<br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH | 8.<br>| Shared Dispositive Power<br>85,740 |  |
| 9.<br>| Aggregate Amount Beneficially Owned by Each Reporting Person<br>85,740 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>85,740 |  |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) | ☐ |
| 11.<br>| Percent of Class Represented by Amount in Row (9)<br>8.95%(1) | Percent of Class Represented by Amount in Row (9)<br>8.95%(1) |  |
| 12. | Type of Reporting Person (See Instructions)<br>OO | Type of Reporting Person (See Instructions)<br>OO |  |

---

(1) Based on an aggregate of 492,610 shares of Common Stock and 438,776 shares of Common Stock underlying Series A Preferred Stock outstanding as of February 2, 2023.

Page 2 of 6 Pages

CUSIP No. 404124307

---

| | | | |
|:---|:---|:---|:---|
| 1. | &nbsp;&nbsp; <br> Names of Reporting Persons.<br>Frederick J. Lynch | &nbsp;&nbsp; <br> Names of Reporting Persons.<br>Frederick J. Lynch |  |
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions) | Check the Appropriate Box if a Member of a Group (See Instructions) | (a) ☐<br> (b) ☒<br>|
| 3. | SEC Use Only | SEC Use Only |  |
| 4. | Citizenship or Place of Organization<br>United States | Citizenship or Place of Organization<br>United States |  |
| NUMBER OF<br> SHARES<br> BENEFICIALLY<br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH | 5. | Sole Voting Power<br>0 |  |
| NUMBER OF<br> SHARES<br> BENEFICIALLY<br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH | 6. | Shared Voting Power<br>85,740 |  |
| NUMBER OF<br> SHARES<br> BENEFICIALLY<br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH | 7.<br>| Sole Dispositive Power<br>0 |  |
| NUMBER OF<br> SHARES<br> BENEFICIALLY<br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH | 8.<br>| Shared Dispositive Power<br>85,740 |  |
| 9.<br>| Aggregate Amount Beneficially Owned by Each Reporting Person<br>85,740 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>85,740 |  |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) | ☐ |
| 11.<br>| Percent of Class Represented by Amount in Row (9)<br>8.95%(1) | Percent of Class Represented by Amount in Row (9)<br>8.95%(1) |  |
| 12. | Type of Reporting Person (See Instructions)<br>IN | Type of Reporting Person (See Instructions)<br>IN |  |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) Based on an aggregate of 492,610 shares of Common Stock and 438,776 shares of Common Stock underlying Series A Preferred Stock outstanding
as of February 2, 2023.

Page 3 of 6 Pages

---

| | | |
|:---|:---|:---|
| **ITEM 1.** | (a) | **Name of Issuer:** H-Cyte, Inc. (the "**Issuer**") |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) **Address of Issuer's Principal Executive Offices:** 

201 E. Kennedy Blvd., Suite 700

Tampa, Florida 33602

---

| | | |
|:---|:---|:---|
| **ITEM 2.** | (a) | **Name of Person Filing:** |

---

This Amendment No. 1 to Schedule 13G is being jointly filed by CFRS Investments, LLC and Frederick J. Lynch (the "**Reporting Persons**").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) **Address of Principal Business Office, or if None, Residence:** 

The address of both Reporting Persons is 2903 W. Villa Rosa Park, Tampa, Florida 33611.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) **Citizenship or Place of Organization:** 

The place of organization of CFRS Investments, LLC is Florida. Mr. Lynch is a United States citizen.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) **Title of Class of Securities:** 

This Amendment No. 1 to Schedule 13G relates to the Issuer's Common Stock, par value $0.001 per share.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) **CUSIP Number:** 

404124307

ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO SS.240.13D-1(B) OR 240.13D-2(B) OR (C), CHECK WHETHER THE PERSON FILING IS A:

Not Applicable.

ITEM 4. OWNERSHIP.

The information required by Item 4 is set forth in Rows 5 – 11 of the cover pages hereto.

---

| | |
|:---|:---|
| ITEM 5. | OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS. |

---

Not Applicable.

---

| | |
|:---|:---|
| ITEM 6. | OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON. |

---

Not Applicable.

ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.

Not Applicable.

Page 4 of 6 Pages

ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.

Not Applicable.

ITEM 9. NOTICE OF DISSOLUTION OF GROUP.

Not Applicable.

ITEM 10. CERTIFICATIONS.

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under Section 240.14a-11.

Page 5 of 6 Pages

**SIGNATURES**

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 10, 2023

---

| |
|:---|
| **CFRS Investments, LLC** |
| By: <u>/s/ Frederick J. Lynch</u> |
| Name: Frederick J. Lynch |
| Title: Manager |
| <u>/s/ Frederick J. Lynch</u> |
| Frederick J. Lynch |

---

Page 6 of 6 Pages